Literature DB >> 32366386

Endometriosis-associated Extraovarian Malignancies: A Challenging Question for the Clinician and the Pathologist.

Angiolo Gadducci1, Gian Franco Zannoni2.   

Abstract

Endometriosis is an estrogen-dependent disease, which affects 10% of women in the reproductive age. Malignant transformation is an uncommon event, which affects approximately 0.7-2.5% of women, and, when it occurs, it involves ovarian and extraovarian sites in 75% and 25% of the cases, respectively. Endometriosis correlates with presentation of clear cell and endometrioid carcinoma of the ovary. Activation of phosphatidylinositol 3-kinase (PIK3) - protein kinase B (AKT) - mammalian target of rapamycin (mTOR) pathway, aberrant chromatin remodeling due to AT-rich interactive domain-containing protein 1A (ARID1A) mutation and inactivation of estrogen receptor-α signaling seem to play a major role in the carcinogenesis. To date, little data are available regarding endometriosis-associated extraovarian malignancies. The aim of the present study was to review the clinical, pathological and prognostic features of endometriosis-related neoplasms arising from extraovarian sites, with particular focus on intestinal malignancies, urinary tract malignancies and tumors arising from surgical scars. Copyright
© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Endometriosis-associated intestinal malignancies; chemotherapy; endometriosis-associated malignancies of surgical scars; endometriosis-associated malignancies of urinary tract; immunohistochemistry; review; surgery

Mesh:

Year:  2020        PMID: 32366386     DOI: 10.21873/anticanres.14212

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  3 in total

1.  Endometriosis: A Retrospective Analysis on Diagnostic Data in a Cohort of 4,401 Patients.

Authors:  Pietro G Signorile; Maria Cassano; Rosa Viceconte; Maria Spyrou; Valentina Marcattilj; Alfonso Baldi
Journal:  In Vivo       Date:  2022 Jan-Feb       Impact factor: 2.155

Review 2.  The Role of mTOR and eIF Signaling in Benign Endometrial Diseases.

Authors:  Tatiana S Driva; Christoph Schatz; Monika Sobočan; Johannes Haybaeck
Journal:  Int J Mol Sci       Date:  2022-03-22       Impact factor: 5.923

Review 3.  Endometriosis and gynaecological cancers: molecular insights behind a complex machinery.

Authors:  Vaclav Vetvicka; Ludek Fiala; Simone Garzon; Giovanni Buzzaccarini; Milan Terzic; Antonio Simone Laganà
Journal:  Prz Menopauzalny       Date:  2021-12-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.